GlassScriptPhysician profile
Franklin R Johnson
NPI 1275522328
$7,160.60
in general payments reported to CMS, 2019-2025
33 companies · $680 in 2025
The $680 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $772 · 2021: $1,057 · 2022: $1,055 · 2023: $1,149 · 2024: $1,275 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,612 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $417 · Education: $64.95 · Grant: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,612.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $416.67 |
| Education | $64.95 |
| Grant | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,534.40 | 2019-2025 | |
| Janssen Biotech, INC. | $773.40 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Lilly USA, LLC | $658.11 | 2019-2024 | Taltz, Olumiant |
| Amgen INC. | $645.33 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $508.37 | 2019-2024 | |
| Pfizer INC. | $440.77 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $351.37 | 2019-2025 | Dupixent |
| Ucb, INC. | $300.66 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $283.25 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Dermavant Sciences, INC. | $229.09 | 2022-2024 | Vtama |
| Leo Pharma INC. | $178.81 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $145.79 | 2019-2023 | |
| Celgene Corporation | $130.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $129.83 | 2022-2025 | Sotyktu |
| Dermira, INC. | $127.13 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $122.94 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $89.94 | 2019-2020 | |
| Almirall LLC | $85.25 | 2019-2025 | Seysara, Klisyri |
| Journey Medical Corporation | $65.99 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.51 | 2023-2024 | Spevigo |
| Mayne Pharma Commercial LLC | $42.69 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $37.71 | 2023-2024 | Zoryve |
| Epi Health, LLC | $27.93 | 2019 | |
| Genentech USA, INC. | $25.47 | 2019 | |
| Mallinckrodt Hospital Products INC. | $25.45 | 2024 | Acthar |
| Verrica Pharmaceuticals INC. | $23.87 | 2023 | Ycanth |
| Encore Dermatology INC. | $23.75 | 2019 | |
| Lnhc, INC | $23.14 | 2025 | Zelsuvmi |
| Merz North America, INC. | $21.48 | 2019 | |
| Botanix Sb INC | $18.37 | 2025 | Sofdra |
| Prugen, INC. Pharmaceuticals | $17.45 | 2020 | |
| Organon LLC | $16.30 | 2025 | Vtama |
| Mylan Pharmaceuticals INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.